CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 71091-71364 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","sourcedb":"CORD-19","sourceid":"3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","text":"The efficacy of the newly approved antibiotics linezolid, daptomycin, and tigecycline will be addressed through the presentation of the results of large phase 3 clinical trials in complicated skin and skin structure infections, hospital-acquired pneumonia, and bacteraemia.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T596","span":{"begin":0,"end":273},"obj":"Sentence"},{"id":"T40696","span":{"begin":0,"end":273},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T596","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T40696","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T154","span":{"begin":0,"end":273},"obj":"Sentence"}],"attributes":[{"subj":"T154","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T55","span":{"begin":246,"end":255},"obj":"Phenotype"}],"attributes":[{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"subj":"T55","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T71","span":{"begin":192,"end":196},"obj":"Body_part"},{"id":"T72","span":{"begin":201,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A71","pred":"uberon_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"A72","pred":"uberon_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T71","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T72","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T245","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T246","span":{"begin":246,"end":255},"obj":"Disease"},{"id":"T65345","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T78401","span":{"begin":246,"end":255},"obj":"Disease"}],"attributes":[{"id":"A245","pred":"mondo_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/MONDO_0043544"},{"id":"A246","pred":"mondo_id","subj":"T246","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A57042","pred":"mondo_id","subj":"T65345","obj":"http://purl.obolibrary.org/obo/MONDO_0043544"},{"id":"A88981","pred":"mondo_id","subj":"T78401","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"subj":"T245","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T246","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T65345","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T78401","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9394ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#aeec93"},{"id":"CORD-19-PD-HP","color":"#ec93c8"},{"id":"CORD-19-PD-UBERON","color":"#93e2ec"},{"id":"CORD-19-PD-MONDO","color":"#ecdc93"}]}]}}